[go: up one dir, main page]

ATE481414T1 - Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung - Google Patents

Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung

Info

Publication number
ATE481414T1
ATE481414T1 AT07731176T AT07731176T ATE481414T1 AT E481414 T1 ATE481414 T1 AT E481414T1 AT 07731176 T AT07731176 T AT 07731176T AT 07731176 T AT07731176 T AT 07731176T AT E481414 T1 ATE481414 T1 AT E481414T1
Authority
AT
Austria
Prior art keywords
cyclopeptide
derived
collagen type
cancer effect
ysns
Prior art date
Application number
AT07731176T
Other languages
English (en)
Inventor
Jean-Claude Monboisse
Laurent Ramont
Sylvie Brassart
Nicolas Floquet
Jessica Thevenard
Original Assignee
Univ Reims Champagne Ardenne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Reims Champagne Ardenne filed Critical Univ Reims Champagne Ardenne
Application granted granted Critical
Publication of ATE481414T1 publication Critical patent/ATE481414T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07731176T 2006-03-23 2007-03-22 Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung ATE481414T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602530A FR2898895B1 (fr) 2006-03-23 2006-03-23 Cyclopeptide a activite anti-cancereuse derive du collagene de type iv
PCT/FR2007/000487 WO2007107654A1 (fr) 2006-03-23 2007-03-22 Cyclopeptide a activite anti-cancereuse derive du collagene de type iv

Publications (1)

Publication Number Publication Date
ATE481414T1 true ATE481414T1 (de) 2010-10-15

Family

ID=37027542

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07731176T ATE481414T1 (de) 2006-03-23 2007-03-22 Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung

Country Status (7)

Country Link
US (1) US20090305955A1 (de)
EP (1) EP1996608B1 (de)
AT (1) ATE481414T1 (de)
DE (1) DE602007009204D1 (de)
ES (1) ES2360004T3 (de)
FR (1) FR2898895B1 (de)
WO (1) WO2007107654A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2490655A (en) 2011-04-28 2012-11-14 Univ Aston Modulators of tissue transglutaminase
US10214561B2 (en) 2014-02-07 2019-02-26 Miyarisan Pharmaceutical Co., Ltd. Peptide having activity of inhibiting production of toxin by bacterium belonging to genus clostridium
CN103897038A (zh) * 2014-04-11 2014-07-02 中国药科大学 一种肿瘤抑制多肽及用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062944A2 (en) * 1998-06-03 1999-12-09 The Children's Medical Center Corporation Protein oligomer compositions comprising endostatin protein and methods of using the same
US20030166003A1 (en) * 1999-06-14 2003-09-04 Cochran Andrea G. Structured peptide scaffold for displaying turn libraries on phage
JP2003519630A (ja) * 2000-01-07 2003-06-24 ベス イスラエル ディーコネス メディカル センター 抗血管新生タンパク質およびその断片ならびに使用方法
US20050239052A1 (en) * 2000-05-18 2005-10-27 Wong Scott W Cloning of rhadinovirus genome and methods for its use
CN1264858C (zh) * 2001-02-16 2006-07-19 纳幕尔杜邦公司 血管生成抑制三肽、组合物及其使用方法
US7714109B2 (en) * 2002-07-15 2010-05-11 Board Of Regents, The University Of Texas System Combinations and kits for cancer treatment using selected antibodies to aminophospholipids

Also Published As

Publication number Publication date
DE602007009204D1 (de) 2010-10-28
ES2360004T3 (es) 2011-05-31
FR2898895A1 (fr) 2007-09-28
EP1996608B1 (de) 2010-09-15
FR2898895B1 (fr) 2012-04-06
WO2007107654A1 (fr) 2007-09-27
WO2007107654A8 (fr) 2009-07-16
EP1996608A1 (de) 2008-12-03
US20090305955A1 (en) 2009-12-10

Similar Documents

Publication Publication Date Title
BR112015016681A8 (pt) uso de nanopartículas compreendendo paclitaxel e uma albumina, kit, medicamento, composição e forma de dosagem unitária para tratamento de câncer pancreático
BR112015022507A2 (pt) ácidos ribonucleicos com nucleotídeos 4'-tio-modificados, composição compreendendo o mesmo e usos relacionados
PL385586A1 (pl) Nowe analogi insuliny o przedłużonym działaniu
MY156243A (en) Treatment for diabetes in patients inappropriate for metformin therapy
UA104600C2 (ru) Комбинированная терапия с применением пептида эпоксикетона
BR112012029975A2 (pt) peptídeo como medicamento, em particular para o tratamento do câncer.
UA117096C2 (uk) Поліпептид, що зв'язується з c5 комплементу людини
BR112015019064A2 (pt) métodos de tratamento de melanoma
CY1110980T1 (el) Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες
MX2009007068A (es) Composiciones y metodos de aplicacion topica y suministro transdermico de toxinas botulinicas estabilizadas con fragmentos de polipeptido provenientes de hiv-tat.
UA108193C2 (uk) Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
PH12015500186A1 (en) Combination therapies for melanoma comprising administering cobimetinib and vemurafinib
EA201390506A1 (ru) Полипептиды, которые связывают компонент с5 комплемента человека
CR20120508A (es) PROTEÍNA DE FUSIÓN ROBO1-Fc Y SU UTILIZACIÓN EN EL TRATAMIENTO DE TUMORES
EP3747457A3 (de) Faktor-1-protein, faktor-2-protein und inhibitoren davon zur verwendung bei der behandlung und prävention von erkrankungen
NZ607892A (en) Tfpi inhibitors and methods of use
ATE510907T1 (de) Adenovirus mit mutationen in der domäne des e3- 19k-proteins zur retention im endoplasmatischen retikulum und verwendung in der krebsbehandlung
EA201200428A1 (ru) Композиция и способ для лечения ожирения
PH12013501205A1 (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
WO2009047513A3 (en) Antagonists of kisspeptin and uses thereof
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
ATE481414T1 (de) Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung
BRPI1006076B8 (pt) composições farmacêuticas
WO2010052243A3 (en) Neurotensin-derived branched peptides and uses thereof
ATE536368T1 (de) Konjugate von zytotoxischen verbindungen mit peptiden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties